methoxyhydroxyphenylglycol has been researched along with Behavior Disorders in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (50.00) | 18.7374 |
1990's | 17 (36.96) | 18.2507 |
2000's | 5 (10.87) | 29.6817 |
2010's | 1 (2.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakker, SC; Borgdorff, P; Bruins, P; Buizer-Voskamp, JE; Cantor, RM; de Jong, S; Derks, EM; DeYoung, J; Eskin, E; Kahn, RS; Kappen, T; Keijzers, P; Lentjes, E; Lu, A; Luykx, JJ; Mentink, L; Neeleman, M; Ophoff, RA; Strengman, E; Sul, JH; van Amerongen, M; van Dongen, EP; van Eijk, K; van Setten, J | 1 |
Duane, DD; Vermilion, KJ | 1 |
Ellis, SP; Harkavy-Friedman, JM; Huang, YY; Mann, JJ; Oquendo, MA; Zalsman, G | 1 |
Abeling, N; Baas, F; Booij, J; Boot, E; de Haan, L; Linszen, D; van Amelsvoort, T; Zinkstok, J | 1 |
Fyrö, B; Gullberg, B; Nybäck, H; Sedvall, G; Wiesel, FA; Wode-Helgodt, B | 1 |
Macfie, C | 1 |
Perris, C; von Knorring, L | 1 |
Asberg, M; Bertilsson, L; Lantto, O; Scalia-Tomba, GP; Träskman-Bendz, L; Tybring, G | 1 |
Fyrö, B; Nybäck, H; Sedvall, G; Wiesel, FA; Wode-Helgodt, B | 1 |
Buchsbaum, MS; Haier, RJ | 1 |
Iselius, L; Nybäck, H; Oreland, L; Oxenstierna, G; Ross, SB; Sedvall, G; Wiesel, FA | 1 |
Potter, WZ | 1 |
Clayton, PJ; Lewis, CE | 1 |
Blennow, K; Gottfries, CG; Månsson, JE; Svennerholm, L; Wallin, A | 1 |
Champoux, M; Goldman, D; Hasert, MF; Higley, JD; Kraemer, GW; Linnoila, M; Scanlan, JM; Suomi, SJ; Thompson, WW | 1 |
Manji, HK; Potter, WZ | 1 |
Brown, GL; Eckardt, MJ; Fils-Aime, ML; George, DT; Linnoila, M; Mefford, I | 1 |
Eggert, M; Linnoila, M; Rawlings, R; Virkkunen, M | 1 |
Brené, S; Crocq, MA; Geijer, T; Gustavsson, JP; Jönsson, E; Lannfelt, L; Schwartz, JC; Sedvall, G; Sokoloff, P; Terenius, L; Tylec, A; Wiesel, FA | 1 |
Bowers, MB | 1 |
Berlin, F; Breakefield, XO; Eisenhofer, G; Ernst, M; George, T; Greenberg, BD; Murphy, DL; Sims, K; Zametkin, A | 1 |
Ekman, R; Fall, PA; Granérus, AK; Thorell, LH; Wålinder, J | 1 |
Fernstrom, J; Fernstrom, M; Greeno, CG; Kaye, WH; Lilenfeld, LR; Mann, JJ; Moss, H; Weltzin, TE | 1 |
Asberg, M; Chotai, J | 1 |
Goldman, D; Lappalainen, J; Linnoila, M; Long, JC; Ozaki, N; Virkkunen, M | 1 |
Alling, C; Blennow, K; Engström, G; Regnéll, G; Träskman-Bendz, L | 1 |
Shigetomi, S | 1 |
Asberg, M; Belfrage, H; Bertilsson, L; Evenden, MM; Lidberg, L | 1 |
Agouridaki, M; Markianos, M; Sarantidis, D; Tripodianakis, J | 1 |
Davies, DS; Dollery, CT; Jones, DH; Murray, S; Reid, JL | 1 |
Goodwin, FK; Gordon, EK; Jimerson, DC; Post, RM | 1 |
Den Boer, JA; Westenberg, HG | 1 |
Gurguis, GN; Uhde, TW | 1 |
Blum, N; Cook, B; Garvey, M; Noyes, R | 1 |
Agren, H; Akerström, G; Hetta, J; Joborn, C; Ljunghall, S; Rastad, J | 1 |
Csernansky, JG; Faull, KF; Pfefferbaum, A | 1 |
Breier, A | 1 |
Brown, RP; Mann, JJ | 1 |
Scheinin, M | 1 |
Edlund, MJ; Swann, AC | 1 |
Boulenger, JP; Zarifian, E | 1 |
Insel, TR; Jimerson, DC; Kafka, M; Kaye, WH; Lake, CR; Murphy, DL; Siever, LJ; Targum, S; Uhde, TW | 1 |
Khan, AU | 1 |
Bowers, MB; Goicoechea, N; Hoffman, FJ; Swigar, ME | 1 |
Gupta, RN; Lew, M; Steiner, M | 1 |
Stancer, HC | 1 |
9 review(s) available for methoxyhydroxyphenylglycol and Behavior Disorders
Article | Year |
---|---|
Cognition and affect in patients with cervical dystonia with and without tremor.
Topics: Affect; Arousal; Cholinergic Antagonists; Cognition; Cognition Disorders; Humans; Learning Disabilities; Mental Disorders; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Psychomotor Performance; Torticollis; Tremor | 2004 |
The year ... psychiatry.
Topics: Affective Symptoms; Behavior Therapy; Brain; Electroconvulsive Therapy; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Psychiatry; Psychophysiologic Disorders; Psychotherapy; Psychotropic Drugs; Schizophrenia | 1980 |
Psychopathology: biological approaches.
Topics: Adoption; Adrenocorticotropic Hormone; Antipsychotic Agents; Brain; Dexamethasone; Diseases in Twins; Evoked Potentials; Genetic Linkage; Genetic Markers; HLA Antigens; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Models, Genetic; Monoamine Oxidase; Radionuclide Imaging; Schizophrenia; Schizophrenia, Paranoid | 1983 |
Genetic studies of CSF monoamine metabolites.
Topics: Biogenic Amines; Blood Platelets; Dopamine beta-Hydroxylase; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Pregnancy; Schizophrenia; Twins, Dizygotic; Twins, Monozygotic | 1984 |
Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.
Topics: Antidepressive Agents; Biogenic Amines; Dopamine; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Mood Disorders; Neurotransmitter Agents; Norepinephrine; Normetanephrine; Psychotropic Drugs; Schizophrenia; Serotonin | 1984 |
[3-methoxy-4-hydroxyphenylglycol (MHPG)].
Topics: Humans; Mental Disorders; Methoxyhydroxyphenylglycol | 1999 |
A clinical perspective on the role of neurotransmitters in mental disorders.
Topics: Antidepressive Agents; Brain Chemistry; Cyclic AMP; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Receptors, Neurotransmitter; Schizophrenia; Serotonin; Suicide | 1985 |
Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Biogenic Amines; Brain Diseases; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetics; Mental Disorders; Methoxyhydroxyphenylglycol; Nervous System Diseases; Neurotransmitter Agents; Phenylacetates | 1985 |
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyphenylalanine; Drug Industry; Electroconvulsive Therapy; Humans; Imipramine; Lithium; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nicotinic Acids; Psychopharmacology; Research Support as Topic; Schizophrenia; Tranquilizing Agents; Tryptophan; Vitamins | 1973 |
3 trial(s) available for methoxyhydroxyphenylglycol and Behavior Disorders
Article | Year |
---|---|
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
Topics: Adult; beta-Endorphin; Blood Platelets; Double-Blind Method; Fear; Female; Fluvoxamine; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Melatonin; Mental Disorders; Methoxyhydroxyphenylglycol; Norepinephrine; Oximes; Panic; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Ritanserin; Serotonin | 1990 |
Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
Topics: Adult; Behavior; Double-Blind Method; Female; Growth Hormone; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Yohimbine | 1990 |
A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.
Topics: Adrenocorticotropic Hormone; Adult; Arousal; beta-Endorphin; Blood Glucose; Clinical Trials as Topic; Deoxyglucose; Depressive Disorder; Double-Blind Method; Epinephrine; Female; Fluphenazine; Grief; Homovanillic Acid; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Mood Disorders; Norepinephrine; Pituitary-Adrenal System; Schizophrenia; Stress, Psychological | 1989 |
34 other study(ies) available for methoxyhydroxyphenylglycol and Behavior Disorders
Article | Year |
---|---|
Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Biogenic Monoamines; Chromosomes, Human, Pair 11; Female; Gene Expression; Genetic Loci; Genetic Variation; Genome-Wide Association Study; Genotyping Techniques; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Linear Models; Male; Membrane Proteins; Mental Disorders; Methoxyhydroxyphenylglycol; Polymorphism, Single Nucleotide; Tumor Suppressor Proteins | 2014 |
Relationship of MAO-A promoter (u-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: A preliminary report.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Catechol O-Methyltransferase; Female; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Linkage Disequilibrium; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Minisatellite Repeats; Monoamine Oxidase; Polymorphism, Genetic; Promoter Regions, Genetic; White People | 2005 |
Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome.
Topics: Adolescent; Adult; Amphetamine; Analysis of Variance; Case-Control Studies; Catechol O-Methyltransferase; Chromatography, High Pressure Liquid; Chromosome Deletion; Chromosomes, Human, Pair 22; Dopamine; Electrochemistry; Female; Genotype; Homovanillic Acid; Humans; Male; Mental Disorders; Methionine; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Prolactin; Synaptic Transmission | 2008 |
Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.
Topics: Adolescent; Adult; Cerebrospinal Fluid Proteins; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Phenylacetates | 1980 |
Biochemistry of the augmenting-reducing response in visual evoked potentials.
Topics: Adult; Aged; Blood Platelets; Dopamine beta-Hydroxylase; Endorphins; Evoked Potentials; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Pain, Intractable; Tryptophan; Visual Pathways | 1981 |
Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
Topics: Body Height; Depressive Disorder; Glycols; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Phenylacetates; Suicide, Attempted | 1982 |
Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Risk | 1982 |
The significance of secondary depression.
Topics: Adult; Age Factors; Depression; Female; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Sex Factors; Sleep, REM; Socioeconomic Factors | 1981 |
Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biogenic Monoamines; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged | 1993 |
Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta).
Topics: Animals; Fathers; Female; Genetic Markers; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Likelihood Functions; Macaca mulatta; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Models, Genetic; Mothers | 1993 |
Are monoamine metabolites in cerebrospinal fluid worth measuring?
Topics: Animals; Brain; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Rats; Research Design; Schizophrenia; Serotonin | 1993 |
Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics.
Topics: Adult; Age of Onset; Alcohol Drinking; Alcoholism; Comorbidity; Family; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Prevalence; Psychiatric Status Rating Scales; Severity of Illness Index; Tryptophan | 1996 |
A prospective follow-up study of alcoholic violent offenders and fire setters.
Topics: Adult; Alcoholism; Cholesterol; Comorbidity; Criminal Law; Family; Finland; Firesetting Behavior; Follow-Up Studies; Forensic Psychiatry; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Prisoners; Prospective Studies; Psychiatric Status Rating Scales; Recurrence; Registries; Violence | 1996 |
Dopamine-related genes and their relationships to monoamine metabolites in CSF.
Topics: Adult; Biogenic Monoamines; Cerebrospinal Fluid; Dopamine; Female; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Polymorphism, Genetic; Receptors, Dopamine; Seasons; Tyrosine 3-Monooxygenase | 1996 |
Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.
Topics: Adult; Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Kidney Failure, Chronic; Levodopa; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Psychotic Disorders; Renal Dialysis | 1996 |
Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
Topics: Adolescent; Adult; Aged; Animals; Attention Deficit Disorder with Hyperactivity; Chromosome Deletion; Chromosome Mapping; Domestic Violence; Humans; Isoenzymes; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Reference Values; Risk Assessment; Selegiline; Sex Offenses; X Chromosome | 1998 |
ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides.
Topics: Aged; Aged, 80 and over; Biogenic Monoamines; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Neuropeptides; Parkinson Disease; Time Factors | 1995 |
Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.
Topics: Adolescent; Adult; Affect; Body Weight; Brain Chemistry; Bulimia; Feeding Behavior; Female; Follow-Up Studies; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Piperazines; Placebos; Prolactin; Psychiatric Status Rating Scales; Serotonin | 1998 |
Variations in CSF monoamine metabolites according to the season of birth.
Topics: Adult; Aged; Analysis of Variance; Biogenic Monoamines; Cohort Effect; Cross-Sectional Studies; Disease Susceptibility; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Seasons; Sweden | 1999 |
HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.
Topics: Alcoholism; Biogenic Monoamines; Brain; Dopamine; Genes; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Norepinephrine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptors, Serotonin | 1999 |
Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Suicide, Attempted | 1999 |
Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders.
Topics: Adult; Disruptive, Impulse Control, and Conduct Disorders; Homicide; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Personality Inventory; Psychiatric Status Rating Scales; Severity of Illness Index; Suicide, Attempted; Violence | 2000 |
Biogenic amine turnover and serum cholesterol in suicide attempt.
Topics: Adult; Biogenic Monoamines; Cholesterol; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Sampling Studies; Suicide, Attempted; Violence | 2002 |
Free and total 3-methoxy-4-hydroxyphenylethylene glycol in human cerebrospinal fluid: relationship to blood pressure in hypertensives and patients with neuropsychiatric disease.
Topics: Adolescent; Adult; Aged; Blood Pressure; Child; Child, Preschool; Female; Glucose; Glycols; Humans; Hypertension; Infant; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged | 1977 |
Central noradrenergic function in man: vanillylmandelic acid in CSF.
Topics: Acute Disease; Affective Symptoms; Bipolar Disorder; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Schizophrenia; Vanilmandelic Acid | 1975 |
Psychiatric family history and urinary MHPG in healthy control subjects.
Topics: Adult; Depressive Disorder; Female; Glycols; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Risk Factors | 1990 |
Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism.
Topics: Aged; Calcium; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hyperparathyroidism; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Prospective Studies | 1988 |
Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
Topics: Bipolar Disorder; Depressive Disorder; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Psychotic Disorders; Retrospective Studies; Schizophrenia; Seasons | 1988 |
Low MHPG and continuing treatment in panic disorder.
Topics: Adult; Age Factors; Alprazolam; Fear; Female; Glycols; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Psychiatric Status Rating Scales | 1989 |
[Peripheral biological markers in psychiatry: value of epidemiologic studies?].
Topics: Catechol O-Methyltransferase; Dexamethasone; Dopamine beta-Hydroxylase; Humans; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Neurotransmitter Agents; Receptors, Neurotransmitter; Synaptic Transmission | 1985 |
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders.
Topics: Adult; Agoraphobia; Anorexia Nervosa; Clonidine; Cyclic AMP; Depressive Disorder; Dihydroergotoxine; Growth Hormone; Humans; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Obsessive-Compulsive Disorder; Panic; Receptors, Adrenergic; Tritium | 1985 |
Biochemical profile of depressed adolescents.
Topics: Adolescent; Depressive Disorder; Dexamethasone; Female; Glycols; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Thyrotropin-Releasing Hormone | 1987 |
Characteristics of patients with the highest plasma catecholamine metabolite levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Depressive Disorder; Feeding and Eating Disorders; Female; Glycols; Homovanillic Acid; Hospitalization; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Psychotic Disorders | 1988 |
Determination of unconjugated 3-methoxy-4-hydroxyphenylglycol by liquid chromatography for monitoring inhibition of monoamine oxidase activity in plasma.
Topics: Blood Platelets; Chromatography, High Pressure Liquid; Glycols; Humans; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenelzine | 1987 |